CNBC (TV) SAYS PFIZER WILL DROP ATTEMPTED TAX INVERSION

 “Pfizer and Allergan [maker of Botox] will mutually terminate their merger early Wednesday morning ET, sources told CNBC, after changes in U.S. tax regulations dealt a death blow to the $160 billion deal.

“Pfizer will pay Allergan a $400 million break fee as per the merger agreement, the sources said.”